Stem Cell Inc.: key financial figures for fiscal year 2022 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2022)
- $0
- Net Income/Loss (FY2022)
- $92.3K
- Total Assets (FY2022)
- $7.7K
- Total Equity (FY2022)
- -$20.3K
- Cash Flows from Operating Activities (FY2022)
- -$24.3K
Source: Stem Cell Inc. 10-K filing (FY2022). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
